Skip to content

Drug interactions

Erlotinib + Secobarbital

Severity: Moderate

Erlotinib and Secobarbital: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Secobarbital may induce CYP3A4 and lower erlotinib exposure, which could reduce antitumour efficacy. Strong inducers are known to lower erlotinib levels substantially.

What this interaction means in plain words

Erlotinib and Secobarbital can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erlotinib belongs to Oncology; Secobarbital belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

CYP3A4 induction by secobarbital increases the hepatic metabolism of erlotinib.

What to do

Prefer a non-inducing alternative to secobarbital. If it is unavoidable, consider increasing the erlotinib dose cautiously while monitoring tolerability, and reduce it again after the inducer is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erlotinib and Secobarbital, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erlotinib with Secobarbital?

MediHelp rates the interaction as moderate. Erlotinib and Secobarbital can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Secobarbital may induce CYP3A4 and lower erlotinib exposure, which could reduce antitumour efficacy. Strong inducers are known to lower erlotinib levels substantially.

How serious is the interaction between Erlotinib and Secobarbital?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing alternative to secobarbital. If it is unavoidable, consider increasing the erlotinib dose cautiously while monitoring tolerability, and reduce it again after the inducer is stopped.

What other medicines interact with Secobarbital?

MediHelp also lists interactions of Secobarbital with, for example, Calcium / magnesium / potassium / sodium oxybates, Doravirine, Elbasvir / grazoprevir. The full list is on the Secobarbital page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in